乙醛脱氢酶2(ALDH2)基因检测对中国汉族人群饮酒行为的影响:单中心、开放标签、随机对照临床试验的研究方案
本研究为单中心、开放标签、随机对照临床试验,计划招募940名18至60岁不健康饮酒者,随机分为干预组和对照组,两组均接受饮酒健康教育,干预组额外进行ALDH2基因检测并出具报告。主要结局为酒精摄入量,次要结局为危险饮酒天数和酒精相关不良事件。
要点
- 计划招募940名18至60岁不健康饮酒者,随机分为干预组和对照组。
- 两组均接受饮酒健康教育,干预组额外进行ALDH2基因检测并出具报告。
- 主要结局为酒精摄入量,次要结局为危险饮酒天数和酒精相关不良事件。
核心结论
- 该试验旨在为ALDH2基因检测对饮酒行为的影响提供有力证据。
研究设计与样本
- 单中心、开放标签、随机对照临床试验,计划招募940名18至60岁不健康饮酒者,随机分为干预组和对照组。
关键数值与推荐
- 两组均接受饮酒健康教育;干预组额外采集血样进行ALDH2基因检测并出具检测报告,对照组不进行ALDH2基因检测。
- 主要结局为酒精摄入量,次要结局为危险饮酒天数和酒精相关不良事件,于干预前后记录。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Alcohol consumption may induce multiple disorders, and decreased alcohol consumption has been proved to be effective to reduce the incidence of alcohol-associated diseases and mortality. Pharmacotherapy is the most common option for the management of alcohol problems; however, it suffers from multiple problems. Non-pharmaceutical interventions are therefore of urgent need to change alcohol intake among alcohol users. Aldehyde dehydrogenase 2 (ALDH2), which encodes the ALDH2 gene, is an important enzyme in ethanol metabolism. Previous studies have demonstrated that individuals harboring ALDH2 gene mutations are more likely to present discomfort symptoms and are more susceptible to multiple cancers. It is hypothesized that ALDH2 gene testing may reduce alcohol consumption and the incidence of alcohol-associated disorders among unhealthy alcohol users. METHODS: A single-center, open-label, randomized, controlled clinical trial was designed, aiming to recruit 940 unhealthy alcohol users at ages of 18 to 60 years. All participants are randomized into the interventional and control groups, and both groups are given alcohol consumption health education. In addition, blood samples are collected from participants in the interventional group for ALDH2 gene testing, with testing reports issued, while ALDH2 gene testing is not performed in the control group. Changes in alcohol intake, hazardous drinking days, and alcohol-associated adverse events are recorded prior to and post-interventions. The primary outcome is alcohol intake, and the secondary outcomes are hazardous drinking days and alcohol-associated adverse events. DISCUSSION: This trial will provide strong evidence regarding the impact of ALDH2 gene testing on alcohol use behaviors. TRIAL REGISTRATION: The study has been registered in the Chinese Clinical Trial Registry (registration no. ChiCTR2400087726) on 2 August 2024.
引用
- Lu D, Wen Y, Liao K, et al. Impact of the aldehyde dehydrogenase 2 (ALDH2) gene testing on alcohol drinking behaviors among the Chinese Han population: study protocol of a single-center, open-label, randomized, controlled clinical trial. Trials. 2025. PMID: 40336132. doi:10.1186/s13063-025-08851-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。